Supply chain management was thrust into the spotlight in 2020 when pandemic disruptions resulted in unprecedented shipping delays and rising costs. Several years later, fallout continues to strain the ...

The biopharmaceutical industry loses approximately $35 billion annually due to temperature-control failures within the supply chain, which often results in products being damaged or destroyed.

Swissmedic has made updates to several of guidances related to active pharmaceutical ingredients (API), temporary authorization, products that receive fast-track authorization, and other documents how ...